TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -2 | 9 | -10 | 0 | 0 | 0 | -1 |
| P | %wins | 0 | 100 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/9/19 21:29 | 1/9/19 | LJPC | La Jolla Pharmaceutical Co | CA | Health | BioPrd | Biological Products, (No Diag | Carver Jennifer | CA | O | COO | P | 31 | 6.17 | 0 | 5 | 70 | 12 | D | ||||||||||||||
8/20/18 21:05 | 8/16/18 | LJPC | La Jolla Pharmaceutical Co | CA | Health | BioPrd | Biological Products, (No Diag | Carver Jennifer | CA | O | COO | P | 21 | 20.90 | 0 | 1 | 18 | 7 | D | ||||||||||||||
2/27/18 21:00 | 2/23/18 | LJPC | La Jolla Pharmaceutical Co | CA | Health | BioPrd | Biological Products, (No Diag | Carver Jennifer | CA | O | COO | P | 32 | 32.48 | 0 | 1 | 22 | 6 | D | ||||||||||||||
12/29/17 17:07 | 12/27/17 | LJPC | La Jolla Pharmaceutical Co | CA | Health | BioPrd | Biological Products, (No Diag | Carver Jennifer | CA | O | COO | P | 33 | 33.22 | 0 | 1 | 29 | 5 | D | ||||||||||||||
3/6/17 16:02 | 3/2/17 | LJPC | La Jolla Pharmaceutical Co | CA | Health | BioPrd | Biological Products, (No Diag | Carver Jennifer | CA | O | COO | P | 34 | 34.46 | 33 | 1 | 40 | 4 | D | 65 | 82 | 111 | 91 | 72 | 77 | 103 | 3 | -2 | 9 | -10 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |